awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45893661-35FB1929-04D5-45F0-96A9-07A13658E8FB
Q45893661-35FB1929-04D5-45F0-96A9-07A13658E8FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45893661-35FB1929-04D5-45F0-96A9-07A13658E8FB
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective.
P2860
Q45893661-35FB1929-04D5-45F0-96A9-07A13658E8FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45893661-35FB1929-04D5-45F0-96A9-07A13658E8FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2de976a1e7eec67210e50a353f5e436c1da37daf
P2860
Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials.